Can we Predict COronary Resistance By EYE Examination ? (COREYE)
COREYE
2 other identifiers
interventional
101
1 country
1
Brief Summary
Prospective interventional study, open, non-comparative and non-randomized. The research concerns physiological parameters of the coronary and ocular blood circulation. At the coronary level, the curves of pressure and Doppler flow will be extracted from ComboMap® (Philips). The coronary microvascular resistances, basal and hyperemic, will be determined by the average ratio of the distal pressure and flow. At the ocular level, a fundus oculi and an OCTA (angiography by tomography in optical coherence) examination will be performed. The measures of the FFR and the coronary microvascular resistance will be determined by a guidewire allowing measures of pressure and by a guidewire allowing measures of Doppler flow (ComboWire®, Volcano), in 123 patients with intermediate stenosis of the left anterior descending artery (LDA). Topological parameters characterizing the retinal area and choriocapillaries will be determined by statistical approaches and mathematical morphology. To establish a predictor of the coronary microvascular resistance from the eye vascular parameters, we shall use a non-linear regression by supervised machine learning. The main cardiovascular risk factors (hypertension, diabetes, dyslipidemia, age, sex) will be part of predetermined input features for the machine learning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started Oct 2018
Longer than P75 for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2018
CompletedFirst Submitted
Initial submission to the registry
November 5, 2018
CompletedFirst Posted
Study publicly available on registry
November 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2024
CompletedDecember 19, 2025
December 1, 2025
5.5 years
November 5, 2018
December 13, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Coronary microvascular resistance results (Combowire)
Estimed by Combowire During coronary angiography, coronary resistance will be measured by pressure and Doppler guides in patients with intermediate coronary stenosis according to the usual procedure. Correlation between results of Combowire® coronary microvascular resistance and OCTA ophthalmologic findings. A machine learning technique will be used to analyze this series of ocular data and to determine a predictor of post-treatment coronary microvascular resistance.
Day 1
Coronary microvascular resistance results (OCTA)
Estimated by ophthalmological examinations data from OCTA. An examination of fundus of the eye will then be performed by optical coherence tomography angiography without injection PLEX Elite 9000. Correlation between results of Combowire® coronary microvascular resistance and OCTA ophthalmologic findings. A machine learning technique will be used to analyze this series of ocular data and to determine a predictor of post-treatment coronary microvascular resistance.
Day 1
Secondary Outcomes (5)
angiographical stenosis
Day 1
Fractional Flow Reserve (FFR)
Day 1
coronary microvascular resistance (CFR)
Day 1
microvascular resistance values
Year 1
total area of flow signal void on the choriocapillaris layer
Year 1
Study Arms (1)
Patient with coronary arterial indication
EXPERIMENTALA fundus oculi and an OCTA (angiography by tomography in optical coherence) examination will be performed for patients with intermediate stenosis of the left anterior descending artery (LDA).
Interventions
The study concerns patients with intermediate stenosis of the left anterior descending artery (LDA). A fundus oculi and an OCTA (angiography by tomography in optical coherence) examination will be performed; it's a non-invasive imaging test. OCT uses light waves to take cross-section pictures of your retina and then ophthalmological examination data will correlate with coronary angiography.
Eligibility Criteria
You may qualify if:
- Male and female patient's ≥18 years of age with coronary arterial indication as usual and with proximal and / or mean IVA stenosis ≥ 50%.
- Signed informed consent
- Affiliation to the social security system
You may not qualify if:
- Unstable Coronary Artery Disease
- Atrial fibrillation
- History of myocardial infarction \<6 months in the territory of the proximal and / or mean IVA.
- Asthma
- Aortocoronary bypass surgery.
- Collateral development at the level of the proximal and / or mean IVA.
- Allergy to iodine, severe renal insufficiency.
- Ametropia\> = 6 diopters.
- History of retinal ocular pathologies other than uncomplicated diabetic retinopathy and hypertensive retinopathy.
- History of ophthalmic treatments such as macular or panretinal laser photocoagulation, intravitreal injection of anti-VEGF or cortisone.
- Chronic glaucoma
- Patients under guardianship or curators.
- Pregnant or lactating women.
- Patient's not affiliated to the French social security.
- Persons placed under the protection of justice,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospices Civils de Lyon - Hopital de la Croix Rousse
Lyon, 69004, France
Related Publications (1)
Harbaoui, B. (2021). Arterial stiffness, physiology, and relevance of interventional cardiology procedures (Habilitation à diriger des recherches thesis). Université Claude Bernard Lyon 1. (Manuscript hosted by CREATIS/INSA Lyon; defense notice by Lyon 1).
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2018
First Posted
November 13, 2018
Study Start
October 4, 2018
Primary Completion
March 20, 2024
Study Completion
March 20, 2024
Last Updated
December 19, 2025
Record last verified: 2025-12